BD 231606 - Disk Susceptibility Sensi-Disc Cefotaxime 30mcg Precision Antibiotic Sensitivity Testing for Gram-Negative and Gram-Positive Bacteria ,EA

BD 231606 - Disk Susceptibility Sensi-Disc Cefotaxime 30mcg Precision Antibiotic Sensitivity Testing for Gram-Negative and Gram-Positive Bacteria ,EA

The BD 231606 Disk Susceptibility Sensi-Disc Cefotaxime 30mcg is a high-quality antimicrobial susceptibility testing reagent designed for standardized disk diffusion methods, such as the Kirby-Bauer technique. Each sterile paper disk contains 30 micrograms of cefotaxime, a third-generation cephalosporin antibiotic widely used for detecting resistance in Gram-negative and some Gram-positive bacterial isolates. Manufactured under BDs strict quality standards, these Sensi-Discs ensure accurate and reproducible antibiotic diffusion, supporting clinical laboratories in identifying effective antimicrobial therapies and monitoring emerging resistance trends.

Key Benefits

The BD 231606 Cefotaxime 30mcg Sensi-Disc offers exceptional accuracy, reliability, and consistency for antimicrobial susceptibility testing (AST). Each disk delivers a precisely measured antibiotic dose for uniform diffusion and consistent inhibition zone formation. The sterile, ready-to-use format minimizes contamination risk, simplifying workflow in busy laboratories. With superior quality control and batch consistency, BDs Sensi-Discs enhance test precision and reliability, enabling laboratories to provide clinicians with dependable results that improve patient care and support antibiotic stewardship efforts.

Compatibility and Applications

The BD 231606 Cefotaxime Sensi-Disc is compatible with standard Mueller-Hinton agar and aligns with CLSI (Clinical and Laboratory Standards Institute) and EUCAST (European Committee on Antimicrobial Susceptibility Testing) guidelines. It is commonly used for testing bacterial isolates such as Escherichia coli, Klebsiella pneumoniae, Enterobacter spp., Proteus mirabilis, and Streptococcus pneumoniae. The cefotaxime 30mcg disk plays a key role in detecting beta-lactam resistance, including extended-spectrum beta-lactamase (ESBL)-producing organisms, in both hospital and reference laboratories.

Usage Guidelines

Use the BD 231606 Cefotaxime Sensi-Disc following CLSI or EUCAST-approved methods. Prepare a standardized bacterial suspension (equivalent to 0.5 McFarland turbidity) and inoculate a Mueller-Hinton agar plate evenly. Apply the cefotaxime 30mcg disk aseptically using sterile forceps or a disk dispenser. Incubate at 3537C for 1618 hours. After incubation, measure the inhibition zone diameter in millimeters and interpret results according to established clinical standards. Store disks at 28C in a dry, dark environment and allow them to equilibrate to room temperature before use to prevent condensation.

Certifications, Safety Standards, and Regulatory Approvals

The BD 231606 Cefotaxime 30mcg Sensi-Disc is produced under ISO 9001 and ISO 13485 certified quality systems and meets FDA and CE regulatory requirements for in vitro diagnostic use. Each batch undergoes comprehensive quality control testing for antibiotic potency, sterility, and diffusion consistency. BDs adherence to global standards ensures laboratories receive highly reliable and validated reagents that meet the most rigorous performance expectations.

Comparison with Competitor Products

Compared to other antibiotic testing disks, BD Sensi-Discs stand out for their consistent diffusion characteristics, precise antibiotic content, and superior packaging integrity. Competitor disks often exhibit variations in antibiotic load and diffusion radius, leading to inconsistent or unreliable results. BDs proprietary manufacturing process ensures uniform drug distribution and enhanced stability, maintaining disk potency even under long-term storage. The moisture-resistant packaging preserves antibiotic activity, giving BD a clear advantage in clinical accuracy and performance.

Typical User Profile and Application Scenarios

The BD 231606 Cefotaxime 30mcg Sensi-Disc is designed for use by microbiologists, laboratory technologists, and infection control specialists. It is ideal for hospital diagnostic laboratories, clinical research facilities, pharmaceutical testing environments, and public health agencies. The disk is used for identifying resistance mechanisms in Gram-negative pathogens, routine antibiotic sensitivity testing, and surveillance of multidrug-resistant bacteria in both patient care and epidemiological studies.

Best Practices for Use and Maintenance

Always handle Sensi-Discs using sterile forceps and aseptic techniques. Ensure proper storage in sealed containers with desiccants to protect against moisture and temperature fluctuations. Use control strains, such as E. coli ATCC 25922 and K. pneumoniae ATCC 700603, for regular performance verification. Avoid using expired or damaged disks, as loss of potency can compromise test accuracy. Dispose of all used disks and inoculated media as biohazard waste following institutional and local safety regulations.

Regulatory and Safety Information

The BD 231606 Sensi-Disc is classified as an in vitro diagnostic reagent intended for use by trained laboratory professionals. It is non-toxic but should be handled under standard biosafety level 2 (BSL-2) laboratory conditions when working with potentially infectious bacterial isolates. The product complies with FDA, CE, and ISO standards for quality and safety in antimicrobial susceptibility testing.

How to Order

To order the BD 231606 Disk Susceptibility Sensi-Disc Cefotaxime 30mcg, add the product to your cart and complete the purchase through CIA Medicals secure online checkout. For institutional bulk purchases, technical documentation, or pricing details, contact CIA Medical customer service at (312) 275-5850 or submit your request via the contact form on this page. Our team will assist you with product availability, certifications, and support for laboratory integration.